165 related articles for article (PubMed ID: 17764755)
21. Expression of nicotinic acetylcholine receptor subunits in HEp-2 cells for immunodetection of autoantibody specificities in sera from Myasthenia gravis patients.
George S; Noack M; Vanek M; Rentzsch J; Röber N; Conrad K; Roggenbuck D; Küpper JH
Clin Hemorheol Microcirc; 2015; 61(2):385-96. PubMed ID: 26410878
[TBL] [Abstract][Full Text] [Related]
22. Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum.
Guo CY; Li ZY; Xu MQ; Yuan JM
J Immunol Methods; 2005 Aug; 303(1-2):142-7. PubMed ID: 16040047
[TBL] [Abstract][Full Text] [Related]
23. Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.
Navaneetham D; Penn A; Howard J; Conti-Fine BM
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):433-42. PubMed ID: 9193799
[TBL] [Abstract][Full Text] [Related]
24. Circular dichroism studies of extracellular domains of human nicotinic acetylcholine receptors provide an insight into their structure.
Zouridakis M; Kostelidou K; Sotiriadis A; Stergiou C; Eliopoulos E; Poulas K; Tzartos SJ
Int J Biol Macromol; 2007 Oct; 41(4):423-9. PubMed ID: 17659334
[TBL] [Abstract][Full Text] [Related]
25. In vitro characterization of an acetylcholine receptor-transferrin fusion protein for the treatment of myasthenia gravis.
Keefe D; Parng C; Lundberg D; Ray S; Martineau-Bosco J; Leng C; Tzartos S; Powell J; Concino M; Heartlein M; Lamsa J; Josiah S
Autoimmunity; 2010 Dec; 43(8):628-39. PubMed ID: 20402568
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
[TBL] [Abstract][Full Text] [Related]
27. Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies.
Fostieri E; Tzartos SJ; Berrih-Aknin S; Beeson D; Mamalaki A
Eur J Immunol; 2005 Feb; 35(2):632-43. PubMed ID: 15627975
[TBL] [Abstract][Full Text] [Related]
28. Mutant forms of the extracellular domain of the human acetylcholine receptor gamma-subunit with improved solubility and enhanced antigenicity. The importance of the Cys-loop.
Bitzopoulou K; Kostelidou K; Poulas K; Tzartos SJ
Biochim Biophys Acta; 2008 Sep; 1784(9):1226-33. PubMed ID: 18502212
[TBL] [Abstract][Full Text] [Related]
29. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis.
MacLennan C; Beeson D; Buijs AM; Vincent A; Newsom-Davis J
Ann Neurol; 1997 Apr; 41(4):423-31. PubMed ID: 9124798
[TBL] [Abstract][Full Text] [Related]
30. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
[TBL] [Abstract][Full Text] [Related]
31. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH
Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
[TBL] [Abstract][Full Text] [Related]
32. Nicotinic acetylcholine receptor mRNAs in myasthenic thymuses: association with intrathymic pathogenesis of myasthenia gravis.
Hara H; Hayashi K; Ohta K; Itoh N; Ohta M
Biochem Biophys Res Commun; 1993 Aug; 194(3):1269-75. PubMed ID: 8352784
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of myasthenia gravis.
Hughes BW; Moro De Casillas ML; Kaminski HJ
Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
[TBL] [Abstract][Full Text] [Related]
34. Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor.
Takamori M; Maruta T
Ther Apher; 2001 Oct; 5(5):340-50. PubMed ID: 11778918
[TBL] [Abstract][Full Text] [Related]
35. Potential roles of recombinant acetylcholine receptor α subunit 1-211 in immunoadsorbent and DNA immunization.
Niu L; Guo C; Hao Z; Yuan J; Li Z
J Immunol Methods; 2011 Sep; 372(1-2):14-21. PubMed ID: 21787780
[TBL] [Abstract][Full Text] [Related]
36. Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus.
Bruno R; Sabater L; Tolosa E; Sospedra M; Ferrer-Francesch X; Coll J; Foz M; Melms A; Pujol-Borrell R
J Neuroimmunol; 2004 Apr; 149(1-2):147-59. PubMed ID: 15020075
[TBL] [Abstract][Full Text] [Related]
37. Differences between the epsilon and gamma subunits of the acetylcholine receptor (AChR) may be significant in autoimmune myasthenia gravis.
Ragheb S; Lisak RP
Ann N Y Acad Sci; 2003 Sep; 998():336-8. PubMed ID: 14592892
[No Abstract] [Full Text] [Related]
38. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
39. Myasthenia gravis experimentally induced with muscle-specific kinase.
Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
[TBL] [Abstract][Full Text] [Related]
40. A new mouse model of autoimmune ocular myasthenia gravis.
Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
